Short Interest in Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) Decreases By 99.0%

Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) was the target of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 100 shares, a decrease of 99.0% from the February 29th total of 9,900 shares. Based on an average daily volume of 37,700 shares, the short-interest ratio is currently 0.0 days.

Mydecine Innovations Group Price Performance

Mydecine Innovations Group stock traded down $0.01 during trading on Thursday, hitting $0.01. The stock had a trading volume of 7,882 shares, compared to its average volume of 26,468. Mydecine Innovations Group has a 1 year low of $0.00 and a 1 year high of $0.66. The stock’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.05.

About Mydecine Innovations Group

Mydecine Innovations Group Inc, a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004.